NCT04639713View on ClinicalTrials.gov

Clinical Study Evaluating the Safety and Effectiveness of The Tixel Fractional System in The Treatment of Periorbital Wrinkles

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

March 2, 2021

Primary Completion Date

April 4, 2022

Study Completion Date

April 4, 2022

Conditions
WrinklePeriorbitalTixel 2FractionalResurfacing
Interventions
DEVICE

Tixel 2

Thermo-mechanical technology for fractional treatment of human skin. Dermal heating and coagulative effect that occur during the treatment session provide dermal remodeling and collagen restructuring that promote wrinkles appearance improvement.

Trial Locations (3)

10016

Laser & Skin Surgery Center of New York, New York

49100

Rabin Medical Center, Ha'Sharon Campus, Petah Tikva

60611

Physicians Laser and Dermatology Institute, Chicago

All Listed Sponsors
lead

Novoxel Ltd.

INDUSTRY

NCT04639713 - Clinical Study Evaluating the Safety and Effectiveness of The Tixel Fractional System in The Treatment of Periorbital Wrinkles | Biotech Hunter | Biotech Hunter